Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Randomized, Double-blind, Placebo-controlled, Multiple-dose, Crossover Study of the Effect of ZT-01 on Frequency of Nocturnal Hypoglycemia in Type 1 Diabetes Mellitus

NCT05762107 is registered in ClinicalTrials.gov with Zucara Therapeutics Inc. as lead sponsor.

NCT NCT05762107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05762107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Randomized, Double-blind, Placebo-controlled, Multiple-dose, Crossover Study of the Effect of ZT-01 on Frequency of Nocturnal Hypoglycemia in Type 1 Diabetes Mellitus
Lead sponsor
Zucara Therapeutics Inc.
Phase
Phase 2
Overall status
Recruiting
Start date
July 28, 2023
Completion date
May 31, 2027
Enrollment
186 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus with hypoglycemia